MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, VRCA has $40,896K in assets. $57,936K in debts. $21,097K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
125.48%
Quick Ratio
117.51%
Cash Ratio
72.98%
Debt to Asset Ratio
141.67%
Assets Breakdown
    • Cash and cash equivalents
    • Accounts receivable
    • Prepaid expenses and other curre...
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Long term debt
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Balance Sheets
2025-09-30
2025-06-30
Cash and cash equivalents
21,097 15,396
Accounts receivable
7,047 9,193
Collaboration receivable, billed and unbilled
282 8,178
Deferred r&d services, current portion (note 11)
1,959 -
Inventory
2,304 2,522
Prepaid expenses and other current assets
3,586 1,492
Total current assets
36,275 36,781
Property and equipment, net
225 315
Operating lease right-of-use asset
616 690
Finance lease right-of-use asset
1,050 945
Deferred r&d services, non-current portion (note 11)
2,354 -
Other non-current assets
376 376
Total assets
40,896 39,107
Deferred revenue
-481
Accounts payable
1,585 2,321
Accrued expenses and other current liabilities
12,600 13,101
Deferred revenue
1,564 -
Current portion of long-term debt
12,458 12,673
Operating lease liability
335 328
Finance lease liability
366 318
Total current liabilities
28,908 29,222
Operating lease liability
330 416
Finance lease liability
629 579
Derivative liability
1,762 1,796
R&d funding liability (note 11)
4,688 -
Long term debt
21,619 24,578
Total liabilities
57,936 56,591
Common stock, 0.0001 par value 200,000,000 authorized 9,500,549 shares issued and 9,490,035 shares outstanding as of september 30, 2025 and 9,188,513 shares issued and 9,177,999 shares outstanding as of december 31, 2024
1 1
Treasury stock, at cost, 10,514 shares as of september 30, 2025 and december 31, 2024
0 0
Additional paid-in capital
299,798 299,080
Accumulated deficit
-316,839 -316,565
Total stockholders deficit
-17,040 -17,484
Total liabilities and stockholders deficit
40,896 39,107
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Prepaid expenses andother current assets$3,586K Inventory$2,304K Deferred r&d services,current portion (note...$1,959K Collaboration receivable,billed and unbilled$282K Accounts receivable$7,047K Cash and cashequivalents$21,097K Other non-currentassets$376K Deferred r&d services,non-current portion (note...$2,354K Finance leaseright-of-use asset$1,050K Operating leaseright-of-use asset$616K Property and equipment,net$225K Total current assets$36,275K Total assets$40,896K Accumulated deficit-$316,839K Total liabilities andstockholders deficit$40,896K Total stockholdersdeficit-$17,040K Additional paid-in capital$299,798K Common stock, 0.0001par value...$1K Total liabilities$57,936K Long term debt$21,619K R&d fundingliability (note 11)$4,688K Derivative liability$1,762K Finance lease liability$629K Operating lease liability$330K Total currentliabilities$28,908K Finance lease liability$366K Operating lease liability$335K Current portion oflong-term debt$12,458K Deferred revenue$1,564K Accrued expenses andother current...$12,600K Accounts payable$1,585K

Verrica Pharmaceuticals Inc. (VRCA)

Verrica Pharmaceuticals Inc. (VRCA)